Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2567511 | Pulmonary Pharmacology & Therapeutics | 2011 | 5 Pages |
Abstract
In the present study, we examined whether there is a difference in the onset of bronchodilatation between formoterol/beclomethasone 12/200 μg Modulite and formoterol/budesonide 9/320 μg Turbuhaler in patients with COPD. We enrolled 28 patients with stable COPD. Both formoterol/beclomethasone and formoterol/budesonide elicited a larger mean FEV1-AUC0â15min than formoterol alone, whereas there was no significant difference between their FEV1-AUC0â15min. Also the change in FEV1 15 min after inhalation of formoterol/beclomethasone combination or formoterol/budesonide combination was greater than that induced by formoterol alone. This study confirms the rapid effect of the inhaled corticosteroid component when combined with formoterol and indicates that the onset of bronchodilation of formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler are similar and greater than formoterol alone in patients with COPD.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Mario Cazzola, Franco Pasqua, Luigi Ferri, Gianluca Biscione, Vittorio Cardaci, Maria Gabriella Matera,